News

Oakley supplies Canadian Olympic team

As the result of a licensing agreement with the Canadian Olympic Committee, Oakley Canada will be the official supplier of high-performance eyewear...

Read More

Quebec product in Bausch + Lomb’s portfolio

Mimetogen, a Montréal pharmaceutical company, has granted Bausch + Lomb an option to license MIM-D3, a treatment for dry-eye syndrome Without...

Read More

Essilor acquires Transitions Optical

Essilor International announced today that it has signed an agreement to acquire the 51% stake in Transitions Optical owned by PPG The French giant...

Read More

Bionic eye no longer mere science fiction

In the 1970s, the American television series “The Six Million Dollar Man” chronicled the adventures of Steve Austin, a hero with a bionic eye...

Read More

Ocular dryness – the new Klondike for pharmaceutical companies

The firm GlobalData predicts that the market value of drugs for dry eye syndrome will triple over the next 10 years According to GlobalData, this...

Read More

Hope in treatment for metastatic uveal melanoma

For the first time, a drug has a real positive impact on patients with metastatic uveal melanoma, a disease often qualified as “untreatable” The...

Read More

Sunburned eyes – even more painful

Protection against UV rays is important all year long However, the arrival of sunny summer days is an ideal time for eyecare professionals to remind...

Read More

The retina: a window to the brain

 The size of retinal blood vessels may indicate brain health, which could help detect early signs of dementia and other cognitive...

Read More

New layer of the cornea discovered

Eyecare professionals will need to revisit their understanding of the human eye, as scientists at the University of Nottingham recently discovered a...

Read More

Fendi arrives at Safilo, Marc Jacobs stays

Safilo has signed a nine-year licensing agreement with Fendi for the design, manufacture and worldwide distribution of Fendi optical frames and...

Read More